Processa Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Processa Pharmaceuticals

30/03/2022 22:01

* Processa Pharmaceuticals Inc  PCSA.OQ  reported a
quarterly
adjusted loss of 21 cents​​ per share for the quarter ended in
December. The mean expectation of three analysts for the quarter
was for a loss of 19 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Processa Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 21 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Processa Pharmaceuticals Inc shares had fallen by 37.8%
this
quarter.
    * The company reported a quarterly loss of $3.18 million.
    * Wall Street's median 12-month price target for Processa
Pharmaceuticals Inc is $17.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 30 at 09:00 p.m.  ​All
figures in US dollars unless otherwise stated